95 related articles for article (PubMed ID: 11907332)
1. Complementation of a p300/CBP defective-binding mutant of adenovirus E1a by human papillomavirus E6 proteins.
Bernat A; Massimi P; Banks L
J Gen Virol; 2002 Apr; 83(Pt 4):829-833. PubMed ID: 11907332
[TBL] [Abstract][Full Text] [Related]
2. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300.
Zimmermann H; Degenkolbe R; Bernard HU; O'Connor MJ
J Virol; 1999 Aug; 73(8):6209-19. PubMed ID: 10400710
[TBL] [Abstract][Full Text] [Related]
3. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.
Patel D; Huang SM; Baglia LA; McCance DJ
EMBO J; 1999 Sep; 18(18):5061-72. PubMed ID: 10487758
[TBL] [Abstract][Full Text] [Related]
4. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.
Huang SM; McCance DJ
J Virol; 2002 Sep; 76(17):8710-21. PubMed ID: 12163591
[TBL] [Abstract][Full Text] [Related]
5. Macrophages kill human papillomavirus type 16 E6-expressing tumor cells by tumor necrosis factor alpha- and nitric oxide-dependent mechanisms.
Routes JM; Morris K; Ellison MC; Ryan S
J Virol; 2005 Jan; 79(1):116-23. PubMed ID: 15596807
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300.
Bernat A; Avvakumov N; Mymryk JS; Banks L
Oncogene; 2003 Sep; 22(39):7871-81. PubMed ID: 12970734
[TBL] [Abstract][Full Text] [Related]
7. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
Sang N; Avantaggiati ML; Giordano A
J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300.
O'Connor MJ; Zimmermann H; Nielsen S; Bernard HU; Kouzarides T
J Virol; 1999 May; 73(5):3574-81. PubMed ID: 10196247
[TBL] [Abstract][Full Text] [Related]
9. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
Thomas MC; Chiang CM
Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
[TBL] [Abstract][Full Text] [Related]
10. Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53.
Zimmermann H; Koh CH; Degenkolbe R; O'Connor MJ; Müller A; Steger G; Chen JJ; Lui Y; Androphy E; Bernard HU
J Gen Virol; 2000 Nov; 81(Pt 11):2617-2623. PubMed ID: 11038372
[TBL] [Abstract][Full Text] [Related]
11. AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins.
Peng YC; Breiding DE; Sverdrup F; Richard J; Androphy EJ
J Virol; 2000 Jul; 74(13):5872-9. PubMed ID: 10846067
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus E1A N-terminal amino acid sequence requirements for repression of transcription in vitro and in vivo correlate with those required for E1A interference with TBP-TATA complex formation.
Boyd JM; Loewenstein PM; Tang Qq QQ; Yu L; Green M
J Virol; 2002 Feb; 76(3):1461-74. PubMed ID: 11773419
[TBL] [Abstract][Full Text] [Related]
13. The adenovirus 12 E1A proteins can bind directly to proteins of the p300 transcription co-activator family, including the CREB-binding protein CBP and p300.
Dorsman JC; Teunisse AF; Zantema A; van der Eb AJ
J Gen Virol; 1997 Feb; 78 ( Pt 2)():423-6. PubMed ID: 9018065
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the mouse ferritin H gene. Involvement of p300/CBP adaptor proteins in FER-1 enhancer activity.
Tsuji Y; Moran E; Torti SV; Torti FM
J Biol Chem; 1999 Mar; 274(11):7501-7. PubMed ID: 10066817
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation.
Hebner C; Beglin M; Laimins LA
J Virol; 2007 Dec; 81(23):12740-7. PubMed ID: 17898049
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors.
Komorek J; Kuppuswamy M; Subramanian T; Vijayalingam S; Lomonosova E; Zhao LJ; Mymryk JS; Schmitt K; Chinnadurai G
J Virol; 2010 Mar; 84(6):2719-31. PubMed ID: 20053746
[TBL] [Abstract][Full Text] [Related]
17. HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53.
Vousden KH; Vojtesek B; Fisher C; Lane D
Oncogene; 1993 Jun; 8(6):1697-702. PubMed ID: 8389035
[TBL] [Abstract][Full Text] [Related]
18. Binding and modulation of p53 by p300/CBP coactivators.
Lill NL; Grossman SR; Ginsberg D; DeCaprio J; Livingston DM
Nature; 1997 Jun; 387(6635):823-7. PubMed ID: 9194565
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human papillomavirus-16 long control region activity by interferon-gamma overcome by p300 overexpression.
Fontaine V; van der Meijden E; ter Schegget J
Mol Carcinog; 2001 May; 31(1):27-36. PubMed ID: 11398195
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
Somasundaram K; El-Deiry WS
Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
